Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Pharmaceutical Business Review image

News from Pharmaceutical Business review

Top Pharmaceutical Business Review News

ALZHEIMER'S ASSOCIATION WELCOMES FDA ACTION APPROVING LEQEMBI WEEKLY SUBCUTANEOUS MAINTENANCE DOSING
Alzheimer's Disease · United States

ALZHEIMER'S ASSOCIATION WELCOMES FDA ACTION APPROVING LEQEMBI WEEKLY SUBCUTANEOUS MAINTENANCE DOSING

67% Right coverage: 3 sources
CHICAGO, Aug. 29, 2025 /PRNewswire/ -- The Alzheimer's Association welcomes today's U.S. Food and Drug Administration (FDA) action to approve weekly subcutaneous maintenance dosing of Leqembi® (lecanemab, Eisai/Biogen) for early Alzheimer's disease. With this approval, Leqembi IQLIK is the first…See the Story
Polpharma Biologics and MS Pharma Sign Licensing Agreements for ...
Pharma

Polpharma Biologics and MS Pharma Sign Licensing Agreements for ...

100% Center coverage: 1 sources
Polpharma Biologics has announced that it has signed licensing agreements with MS Pharma for the commercialisation of its biosimilar candidates vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) in the MENA region.See the Story
FDA Grants Breakthrough Therapy Designation to Olomorasib With Pembrolizumab for NSCLC
Pharma · United States

FDA Grants Breakthrough Therapy Designation to Olomorasib With Pembrolizumab for NSCLC

The FDA designates olomorasib as a breakthrough therapy, enhancing treatment options for advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutations.See the Story

Breaking News Topics Related to Pharmaceutical Business Review

Canada icon

Canada

China icon

China

Germany icon

Germany

Cancer icon

Cancer

Pharma icon

Pharma

United States icon

United States

FDA icon

FDA

News
For You
SearchBlindspotLocal